Cancer Stem Cells Therapy Market
PUBLISHED: 2024 ID: SMRC24716
SHARE
SHARE

Cancer Stem Cells Therapy Market

Cancer Stem Cells Therapy Market Forecasts to 2030 - Global Analysis By Cancer Type (Brain Cancer Stem Cells Therapy, Breast Cancer Stem Cells Therapy, Colorectal Cancer Stem Cells Therapy, Lung Cancer Stem Cells Therapy, Prostate Cancer Stem Cells Therapy and Other Cancer Types), Therapeutic Type, End User and By Geography

4.2 (48 reviews)
4.2 (48 reviews)
Published: 2024 ID: SMRC24716

This report covers the impact of COVID-19 on this global market
Loading...

Years Covered

2021-2030

Estimated Year Value (2023)

US $4.9 BN

Projected Year Value (2030)

US $11.1 BN

CAGR (2023 - 2030)

12.2%

Regions Covered

North America, Europe, Asia Pacific, South America, and Middle East & Africa

Countries Covered

US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa

Largest Market

Asia Pacific

Highest Growing Market

Asia Pacific


According to Stratistics MRC, the Global Cancer Stem Cells Therapy Market is accounted for $4.9 billion in 2023 and is expected to reach $11.1 billion by 2030 growing at a CAGR of 12.2% during the forecast period. The Cancer Stem Cells Therapy involves the development and implementation of therapeutic strategies specifically targeting cancer stem cells (CSCs), a subpopulation of cells within tumors believed to possess self-renewal and differentiation capabilities. These cells are implicated in tumor initiation, progression, and treatment resistance. Cancer stem cell therapy aims to eradicate or inhibit the growth of these cells, thereby addressing the root cause of cancer and preventing relapse. 

According to World Health Organization (WHO), cancer was the leading cause of death worldwide, accounting for nearly 10 million deaths in 2020.

Market Dynamics: 

Driver: 

Growing emphasis on personalized medicine

Due to the intricate molecular and genetic factors influencing cancer advances, there is a paradigm shift towards tailoring treatments based on individual patient characteristics. Cancer stem cells, with their distinct molecular profiles, play a pivotal role in tumor development and recurrence. The emphasis on personalized medicine aligns seamlessly with the objective of targeting these specific cellular components, allowing for more precise and effective therapeutic interventions. Additionally, by customizing cancer stem cell therapies to the unique genetic makeup of each patient, the potential for improved treatment outcomes and reduced side effects becomes apparent.

Restraint:

High development costs

The intricate nature of cancer stem cell research, coupled with the stringent regulatory requirements for clinical trials and drug approvals, contributes to substantial financial investments. The extensive research needed to unravel the complexities of cancer stem cells, conduct preclinical studies, and progress through rigorous clinical trial phases amplifies development expenses. Moreover, the uncertainty associated with the success and commercial viability of these therapies adds to the financial risk. Pharmaceutical companies and research institutions face the challenge of balancing the imperative to innovate with the financial burden of bringing novel cancer stem cell therapies to market.

Opportunity:

Increasing investment in oncology research

As the understanding of cancer biology evolves, there is a growing recognition of the pivotal role played by cancer stem cells in tumor initiation and progression. This realization has prompted a surge in research funding, both from public and private sectors, dedicated to unraveling the complexities of cancer stem cells and developing targeted therapies. The heightened focus on identifying innovative treatment modalities and advancing scientific knowledge in oncology creates a conducive environment for the emergence of novel cancer stem cell therapies.

Threat:

Ethical and regulatory concerns

The intricate nature of stem cell research, including the use of embryonic stem cells, raises ethical considerations surrounding the source and derivation of cells for therapy. This has prompted ongoing debates and, at times, regulatory restrictions, creating hurdles in the development and acceptance of certain stem cell-based treatments. Additionally, stringent regulatory frameworks governing clinical trials and therapeutic approvals contribute to the challenges faced by researchers and developers in bringing cancer stem cell therapies to market.

Covid-19 Impact: 

While the crisis emphasized the urgent need for innovative therapies, including those targeting cancer stem cells, disruptions in research activities, clinical trials, and healthcare services have impeded the market's trajectory. The redirection of resources toward pandemic-related efforts, delays in clinical trial timelines, and challenges in patient recruitment have slowed down the pace of cancer stem cell therapy development. Additionally, economic uncertainties and shifts in healthcare priorities have influenced funding availability and investment patterns in the sector.

The breast cancer stem cells therapy segment is expected to be the largest during the forecast period

Breast Cancer Stem Cells Therapy segment dominated the largest share of the market over the forecast period due to its targeted approach in treating breast cancer at its roots. The therapeutic focus on these specific cells allows for more effective and sustained treatment outcomes, reducing the likelihood of cancer relapse. This precision in targeting cancer stem cells enhances the overall efficacy of therapies, contributing to increased adoption and demand in the market. Additionally, ongoing research and advancements in understanding the molecular mechanisms of breast cancer stem cells further fuel the development of innovative therapies, attracting investments and driving market expansion.

The gene therapy segment is expected to have the highest CAGR during the forecast period

Gene Therapy segment is estimated to witness lucrative growth over the projection period due to the advanced genetic techniques to specifically target and modify cancer stem cells. Gene therapy enables the introduction of therapeutic genes or the manipulation of existing ones to disrupt the signaling pathways crucial for the survival and proliferation of cancer stem cells. Furthermore, this innovative approach not only enhances the precision of cancer treatment but also minimizes damage to normal cells, reducing side effects. 

Region with largest share:

Asia Pacific region commanded the largest market share over the extrapolated period due to a surge in cancer incidence, with breast, lung, and colorectal cancers being particularly prevalent. This high disease burden has spurred increased investments in advanced medical research and treatment modalities, creating a conducive environment for the expansion of cancer stem cell therapies. Moreover, the Asia Pacific region has experienced rapid technological advancements and innovation in the healthcare sector, fostering the development of cutting-edge therapies, including those targeting cancer stem cells.

Region with highest CAGR:

Asia Pacific region is projected to grow at a rapid pace owing to a strong focus on research and development, coupled with a burgeoning biotechnology and pharmaceutical industry, has paved the way for the discovery of novel therapeutic approaches that specifically target cancer stem cells, enhancing treatment efficacy. As a result, there is a notable increase in the adoption of cancer stem cell therapies, driven by the demand for more precise and tailored treatment options. Additionally, governments and regulatory bodies in the region are also actively supporting advancements in healthcare infrastructure, research initiatives, and clinical trials, creating an environment conducive to the rapid integration of novel therapies into mainstream cancer care.

Key players in the market

Some of the key players in Cancer Stem Cells Therapy market include AbbVie Inc., AdnaGen AG, Astellas Pharma Inc., Bristol Myers Squibb, Cancer Stem Cells Co., Ltd, Gamida Cells, Glycosyn LLC, Johnson & Johnson, Merck & Co., Inc., Novadip Biosciences, Novartis AG, OncoMed Pharmaceuticals, Pfizer Inc, Roche Holdings AG, Stemline Therapeutics, Inc. and Thermo Fisher Scientific, Inc.

Key Developments:

In December 2023, Novartis receives FDA approval for Fabhalta® (iptacopan), offering superior hemoglobin improvement in the absence of transfusions as the first oral monotherapy for adults with PNH. Significant unmet need remains in PNH, a chronic and rare blood disorder; despite anti-C5 therapy, a large proportion of patients can remain anemic and dependent on blood transfusions

In July 2023, US FDA approves expanded indication for Novartis Leqvio® (inclisiran) to include treatment of adults with high LDL-C and who are at increased risk of heart disease. Leqvio can now be used earlier in LDL-C treatment as an adjunct to diet and statin therapy for patients who have not had a cardiovascular event but are at an increased risk of heart disease

Cancer Types Covered:
• Brain Cancer Stem Cells Therapy
• Breast Cancer Stem Cells Therapy
• Colorectal Cancer Stem Cells Therapy
• Lung Cancer Stem Cells Therapy
• Prostate Cancer Stem Cells Therapy
• Other Cancer Types 

Therapeutic Types Covered:
• Chemotherapy
• Immunotherapy
• Radiation Therapy
• Stem Cell Transplantation
• Targeted Therapy
• Differentiation Therapy
• Gene Therapy
• Nanoparticle-Based Therapies
• Combination Therapies
• Other Therapeutic Types

End Users Covered:
• Cancer Research Institutes
• Hospitals
• Specialty Clinics
• Academic Medical Centers
• Healthcare Professionals
• Other End Users

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan        
o China        
o India        
o Australia  
o New Zealand
o South Korea
o Rest of Asia Pacific    
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa 
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings: 
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary      
       
2 Preface      
 2.1 Abstract     
 2.2 Stake Holders     
 2.3 Research Scope     
 2.4 Research Methodology     
  2.4.1 Data Mining    
  2.4.2 Data Analysis    
  2.4.3 Data Validation    
  2.4.4 Research Approach    
 2.5 Research Sources     
  2.5.1 Primary Research Sources    
  2.5.2 Secondary Research Sources    
  2.5.3 Assumptions    
       
3 Market Trend Analysis      
 3.1 Introduction     
 3.2 Drivers     
 3.3 Restraints     
 3.4 Opportunities     
 3.5 Threats     
 3.6 End User Analysis     
 3.7 Emerging Markets     
 3.8 Impact of Covid-19     
       
4 Porters Five Force Analysis      
 4.1 Bargaining power of suppliers     
 4.2 Bargaining power of buyers     
 4.3 Threat of substitutes     
 4.4 Threat of new entrants     
 4.5 Competitive rivalry     
       
5 Global Cancer Stem Cells Therapy Market, By Cancer Type      
 5.1 Introduction     
 5.2 Brain Cancer Stem Cells Therapy     
 5.3 Breast Cancer Stem Cells Therapy     
 5.4 Colorectal Cancer Stem Cells Therapy     
 5.5 Lung Cancer Stem Cells Therapy     
 5.6 Prostate Cancer Stem Cells Therapy     
 5.7 Other Cancer Types     
       
6 Global Cancer Stem Cells Therapy Market, By Therapeutic Type      
 6.1 Introduction     
 6.2 Chemotherapy     
 6.3 Immunotherapy     
 6.4 Radiation Therapy     
 6.5 Stem Cell Transplantation     
 6.6 Targeted Therapy     
 6.7 Differentiation Therapy     
 6.8 Gene Therapy     
 6.9 Nanoparticle-Based Therapies     
 6.10 Combination Therapies     
 6.11 Other Therapeutic Types     
       
7 Global Cancer Stem Cells Therapy Market, By End User      
 7.1 Introduction     
 7.2 Cancer Research Institutes     
 7.3 Hospitals     
 7.4 Specialty Clinics     
 7.5 Academic Medical Centers     
 7.6 Healthcare Professionals     
  7.6.1 Surgeons    
  7.6.2 Radiation Oncologists    
  7.6.3 Hematologists    
 7.7 Other End Users     
       
8 Global Cancer Stem Cells Therapy Market, By Geography      
 8.1 Introduction     
 8.2 North America     
  8.2.1 US    
  8.2.2 Canada    
  8.2.3 Mexico    
 8.3 Europe     
  8.3.1 Germany    
  8.3.2 UK    
  8.3.3 Italy    
  8.3.4 France    
  8.3.5 Spain    
  8.3.6 Rest of Europe    
 8.4 Asia Pacific     
  8.4.1 Japan    
  8.4.2 China    
  8.4.3 India    
  8.4.4 Australia    
  8.4.5 New Zealand    
  8.4.6 South Korea    
  8.4.7 Rest of Asia Pacific    
 8.5 South America     
  8.5.1 Argentina    
  8.5.2 Brazil    
  8.5.3 Chile    
  8.5.4 Rest of South America    
 8.6 Middle East & Africa     
  8.6.1 Saudi Arabia    
  8.6.2 UAE    
  8.6.3 Qatar    
  8.6.4 South Africa    
  8.6.5 Rest of Middle East & Africa    
       
9 Key Developments      
 9.1 Agreements, Partnerships, Collaborations and Joint Ventures     
 9.2 Acquisitions & Mergers     
 9.3 New Product Launch     
 9.4 Expansions     
 9.5 Other Key Strategies     
       
10 Company Profiling      
 10.1 AbbVie Inc.     
 10.2 AdnaGen AG     
 10.3 Astellas Pharma Inc.     
 10.4 Bristol Myers Squibb     
 10.5 Cancer Stem Cells Co., Ltd     
 10.6 Gamida Cells     
 10.7 Glycosyn LLC     
 10.8 Johnson & Johnson     
 10.9 Merck & Co., Inc.     
 10.10 Novadip Biosciences     
 10.11 Novartis AG     
 10.12 OncoMed Pharmaceuticals     
 10.13 Pfizer Inc     
 10.14 Roche Holdings AG     
 10.15 Stemline Therapeutics, Inc.     
 10.16 Thermo Fisher Scientific, Inc     
       
List of Tables       
1 Global Cancer Stem Cells Therapy Market Outlook, By Region (2021-2030) ($MN)      
2 Global Cancer Stem Cells Therapy Market Outlook, By Cancer Type (2021-2030) ($MN)      
3 Global Cancer Stem Cells Therapy Market Outlook, By Brain Cancer Stem Cells Therapy (2021-2030) ($MN)      
4 Global Cancer Stem Cells Therapy Market Outlook, By Breast Cancer Stem Cells Therapy (2021-2030) ($MN)      
5 Global Cancer Stem Cells Therapy Market Outlook, By Colorectal Cancer Stem Cells Therapy (2021-2030) ($MN)      
6 Global Cancer Stem Cells Therapy Market Outlook, By Lung Cancer Stem Cells Therapy (2021-2030) ($MN)      
7 Global Cancer Stem Cells Therapy Market Outlook, By Prostate Cancer Stem Cells Therapy (2021-2030) ($MN)      
8 Global Cancer Stem Cells Therapy Market Outlook, By Other Cancer Types (2021-2030) ($MN)      
9 Global Cancer Stem Cells Therapy Market Outlook, By Therapeutic Type (2021-2030) ($MN)      
10 Global Cancer Stem Cells Therapy Market Outlook, By Chemotherapy (2021-2030) ($MN)      
11 Global Cancer Stem Cells Therapy Market Outlook, By Immunotherapy (2021-2030) ($MN)      
12 Global Cancer Stem Cells Therapy Market Outlook, By Radiation Therapy (2021-2030) ($MN)      
13 Global Cancer Stem Cells Therapy Market Outlook, By Stem Cell Transplantation (2021-2030) ($MN)      
14 Global Cancer Stem Cells Therapy Market Outlook, By Targeted Therapy (2021-2030) ($MN)      
15 Global Cancer Stem Cells Therapy Market Outlook, By Differentiation Therapy (2021-2030) ($MN)      
16 Global Cancer Stem Cells Therapy Market Outlook, By Gene Therapy (2021-2030) ($MN)      
17 Global Cancer Stem Cells Therapy Market Outlook, By Nanoparticle-Based Therapies (2021-2030) ($MN)      
18 Global Cancer Stem Cells Therapy Market Outlook, By Combination Therapies (2021-2030) ($MN)      
19 Global Cancer Stem Cells Therapy Market Outlook, By Other Therapeutic Types (2021-2030) ($MN)      
20 Global Cancer Stem Cells Therapy Market Outlook, By End User (2021-2030) ($MN)      
21 Global Cancer Stem Cells Therapy Market Outlook, By Cancer Research Institutes (2021-2030) ($MN)      
22 Global Cancer Stem Cells Therapy Market Outlook, By Hospitals (2021-2030) ($MN)      
23 Global Cancer Stem Cells Therapy Market Outlook, By Specialty Clinics (2021-2030) ($MN)      
24 Global Cancer Stem Cells Therapy Market Outlook, By Academic Medical Centers (2021-2030) ($MN)      
25 Global Cancer Stem Cells Therapy Market Outlook, By Healthcare Professionals (2021-2030) ($MN)      
26 Global Cancer Stem Cells Therapy Market Outlook, By Surgeons (2021-2030) ($MN)      
27 Global Cancer Stem Cells Therapy Market Outlook, By Radiation Oncologists (2021-2030) ($MN)      
28 Global Cancer Stem Cells Therapy Market Outlook, By Hematologists (2021-2030) ($MN)      
29 Global Cancer Stem Cells Therapy Market Outlook, By Other End Users (2021-2030) ($MN)      
       
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.       

List of Figures

RESEARCH METHODOLOGY


Research Methodology

We at Stratistics opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.

Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.

Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.

Data Mining

The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.

Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.

Data Analysis

From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:

  • Product Lifecycle Analysis
  • Competitor analysis
  • Risk analysis
  • Porters Analysis
  • PESTEL Analysis
  • SWOT Analysis

The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.


Data Validation

The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.

We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.


For more details about research methodology, kindly write to us at info@strategymrc.com

Frequently Asked Questions

In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.

Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.

All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929

We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

We have 3 different licensing options available in electronic format.

  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.

All our reports are typically be emailed to you as an attachment.

To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.

We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

Request Customization

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials